Literature DB >> 7890656

Radicicol, a protein tyrosine kinase inhibitor, suppresses the expression of mitogen-inducible cyclooxygenase in macrophages stimulated with lipopolysaccharide and in experimental glomerulonephritis.

P Chanmugam1, L Feng, S Liou, B C Jang, M Boudreau, G Yu, J H Lee, H J Kwon, T Beppu, M Yoshida.   

Abstract

Two isoforms of cyclooxygenase (COX) have been identified in eukaryotic cells: a constitutively expressed COX-1 and mitogen-inducible COX-2, which is selectively expressed in response to various inflammatory stimuli. Thus, COX-2 instead of COX-1 is implicated to produce prostanoids mediating inflammatory responses. Major efforts have been focused on identifying nonsteroidal anti-inflammatory drugs (NSAIDS) which can selectively inhibit the enzyme activity of COX-2. Such NSAIDS would be more desirable anti-inflammatory agents in comparison to NSAIDS which inhibit both COX-1 and COX-2. Other than glucocorticoids, pharmacological agents which can selectively suppress the expression of COX-2 without affecting that of COX-1 have not been identified. We report here that radicicol, a fungal antibiotic, is a potent protein tyrosine kinase inhibitor, and that it inhibits the expression of COX-2 without affecting COX-1 expression in lipopolysaccharide (LPS)-stimulated macrophages with the IC50 value of 27 nM. Radicicol inhibited tyrosine phosphorylation of p53/56lyn, a Src family tyrosine kinase and one of the major tyrosine-phosphorylated proteins in LPS-stimulated macrophages. Radicicol also inhibited COX-2 expression in vivo in glomeruli of rats with experimental glomerulonephritis induced by the anti-glomerular basement membrane antibodies, in which COX-2 expression is known to be enhanced. The enzyme activity of COX-1 or COX-2 was not affected by radicicol in macrophages. Radiciciol also suppressed the COX-2 expression induced by IL-1 beta in rat smooth muscle cells. Other protein tyrosine kinase inhibitors suppressed the LPS-induced COX-2 expression in macrophages but at much higher concentrations than needed for radicicol. Radicicol did not inhibit the COX-2 expression induced by phorbol 12-myristate 13-acetate in macrophages. These results suggest that the activation of tyrosine-specific protein kinases is the proximal obligatory step in the LPS-induced signal transduction pathway leading to the induction of COX-2 expression in macrophages. The magnitude of the inhibition of COX-2 protein synthesis by radicicol was much greater than that of the steady state levels of COX-2 mRNA. These results suggest that radicicol inhibits COX-2 expression mainly at post-transcriptional steps.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7890656     DOI: 10.1074/jbc.270.10.5418

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  13 in total

Review 1.  Novel pharmacological strategies for analgesia.

Authors:  M Perkins; A Dray
Journal:  Ann Rheum Dis       Date:  1996-10       Impact factor: 19.103

2.  Identification and inhibitory properties of a novel Ca(2+)/calmodulin antagonist.

Authors:  Josep Colomer; Allison A Schmitt; Eric J Toone; Anthony R Means
Journal:  Biochemistry       Date:  2010-05-18       Impact factor: 3.162

3.  Prostaglandin production via induction of cyclooxygenase-2 by human gingival fibroblasts stimulated with lipopolysaccharides.

Authors:  K Noguchi; M Shitashige; M Yanai; I Morita; T Nishihara; S Murota; I Ishikawa
Journal:  Inflammation       Date:  1996-10       Impact factor: 4.092

4.  Induction of prostanoid, nitric oxide, and cytokine formation in rat bone marrow derived macrophages by activin A.

Authors:  R M Nüsing; J Barsig
Journal:  Br J Pharmacol       Date:  1999-06       Impact factor: 8.739

5.  Protein-tyrosine-kinase-dependent expression of cyclo-oxygenase-1 and -2 mRNAs in human endothelial cells.

Authors:  K Hirai; H Takayama; K Tomo; M Okuma
Journal:  Biochem J       Date:  1997-03-01       Impact factor: 3.857

Review 6.  Cyclooxygenase 2: protein-protein interactions and posttranslational modifications.

Authors:  Anna Alexanian; Andrey Sorokin
Journal:  Physiol Genomics       Date:  2017-09-22       Impact factor: 3.107

7.  Cyclooxygenase 2 promotes cell survival by stimulation of dynein light chain expression and inhibition of neuronal nitric oxide synthase activity.

Authors:  Y W Chang; R Jakobi; A McGinty; M Foschi; M J Dunn; A Sorokin
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

8.  Antifungal and Cytotoxic β-Resorcylic Acid Lactones from a Paecilomyces Species.

Authors:  Liangxiong Xu; Ping Wu; Jinghua Xue; Istvan Molnar; Xiaoyi Wei
Journal:  J Nat Prod       Date:  2017-07-27       Impact factor: 4.050

Review 9.  Discovery of a new function of cyclooxygenase (COX)-2: COX-2 is a cardioprotective protein that alleviates ischemia/reperfusion injury and mediates the late phase of preconditioning.

Authors:  Roberto Bolli; Ken Shinmura; Xian-Liang Tang; Eitaro Kodani; Yu-Ting Xuan; Yiru Guo; Buddhadeb Dawn
Journal:  Cardiovasc Res       Date:  2002-08-15       Impact factor: 10.787

10.  Involvement of tyrosine kinases in the induction of cyclo-oxygenase-2 in human endothelial cells.

Authors:  A Blanco; A Habib; S Levy-Toledano; J Maclouf
Journal:  Biochem J       Date:  1995-12-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.